B. Gazzard

IFITM3 restricts the morbidity and mortality associated with influenza

C. Tyler-Smith, S. Clare, G. Dougan, 2012, Nature.

The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era.

B. Gazzard, A. Mocroft, O. Kirk, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

British HIV Association and Children's HIV Association position statement on infant feeding in the UK 2011

J. Anderson, M. Newell, B. Gazzard, 2011, HIV medicine.

Long-term efficacy and safety of a treatment strategy for HIV infection using protease inhibitor monotherapy: 8-year routine clinical care follow-up from a randomised, controlled, open-label pragmatic trial (PIVOT)

J. Ainsworth, M. Gompels, A. Arenas-Pinto, 2024, EClinicalMedicine.

The incidence of AIDS-defining illnesses in 4883 patients with human immunodeficiency virus infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.

A. Mocroft, R. Halai, A. Phillips, 1998, Archives of internal medicine.